<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------
FORM 8-K/A
(Amendment No.1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 24, 1998
--------------
INFOCURE CORPORATION
------------------------------------------------------
(exact name of registrant as specified in chapter)
<TABLE>
<CAPTION>
<S> <C> <C>
Delaware 001-12799 58-2271614
- ---------------------------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
</TABLE>
<TABLE>
<CAPTION>
<S> <C>
1765 The Exchange, Suite 450, Atlanta, GA 30339
- ------------------------------------------------------------------------------------------------
(Address of principal executive office) (zip code)
</TABLE>
<TABLE>
<CAPTION>
<S> <C>
Registrant's telephone number, including area code: 770-221-9990
------------
</TABLE>
Not Applicable
--------------
(Former name or former address, if changed since last report)
<PAGE>
Contents
--------
Page
Item 7: Financial Statements......................... 3
Signatures............................................ 4
<PAGE>
Item 7. Financial Statements.
On February 23, 1998, InfoCure Corporation (the "Company") filed a
Current Report on Form 8-K to report the Company's acquisition of all of the
outstanding capital stock of PACE Financial Corporation, an Ohio corporation.
In such report, the Company indicated that the Company's financial statements
and pro forma financial information relating to the acquisition were unavailable
at that time and would be filed as soon as practicable. The Company has since
determined that such financial statements and pro forma financial information
need not be filed with the Commission according to Regulation S-X under the
Securities Exchange Act of 1934.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INFOCURE CORPORATION
/s/ Frederick L. Fine
------------------------------
Date: April 24, 1998 Frederick L. Fine
Chairman, President and
Chief Executive Officer
